GenomesDAO GENOME is projected to decline to $0.0003247 by 2027, a -21% move from its current price of $0.0004135. GENOME is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell. Market sentiment sits at 22/100 (Extreme Fear) on the Fear & Greed Index.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via CoinGecko & CoinMarketCap · updated 5/26/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $0.0003894 | $0.0004138 | $0.0004397 | +0.08% |
| May 30 | $0.0003801 | $0.0004141 | $0.0004513 | +0.16% |
| May 31 | $0.0003731 | $0.0004145 | $0.0004604 | +0.23% |
| Jun 1 | $0.0003674 | $0.0004148 | $0.0004684 | +0.31% |
| Jun 2 | $0.0003624 | $0.0004151 | $0.0004755 | +0.39% |
| Jun 3 | $0.000358 | $0.0004154 | $0.0004821 | +0.47% |
| Jun 4 | $0.000354 | $0.0004158 | $0.0004882 | +0.55% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.000354 | $0.0004158 | $0.0004882 | +0.55% |
| Week 2 | $0.0003331 | $0.000418 | $0.0005247 | +1.09% |
| Week 3 | $0.0003182 | $0.0004203 | $0.0005552 | +1.65% |
| Week 4 | $0.0003065 | $0.0004226 | $0.0005827 | +2.20% |
| Week 5 | $0.0002967 | $0.0004249 | $0.0006086 | +2.76% |
| Week 6 | $0.0002882 | $0.0004272 | $0.0006332 | +3.32% |
| Week 7 | $0.0002808 | $0.0004296 | $0.0006571 | +3.88% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
GENOME is the new token from GenomesDAO, replacing $GENE and $GNOME to create one new super utility token for the Genomes platform. It sits within the Ethereum Ecosystem, Base Ecosystem, and Decentralized Science (DeSci) category space, reflecting its role across several interconnected ecosystems.
As a cryptocurrency token, GENOME is positioned as the core unit for the Genomes platform within its described sector, designed to function as a streamlined, single-token utility asset for Genomes activities and services. Its branding centers on consolidating prior tokens into one unified token for platform use.
GenomesDAO GENOME is currently priced at $0.0004135 with a market cap of $413.17K, and it ranks 3984 by market capitalization. The token’s current price and market position place it among smaller-cap assets, with all-time high and low noted as $0.0586 and $0.0002974 respectively. The price outlook shows a mix of outcomes across multiple years, with near-term movement centered around the current price and a broad range of potential future levels.
A major floor 52.6% below — a decisive break under it would weaken the trend.
The nearest floor, 24.6% below — buyers have tended to step in here.
The nearest ceiling, 29.7% above — a clean break opens room to run.
A major ceiling 63.2% above — clearing it would confirm fresh momentum.
Key GENOME support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of GENOME market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.0003707 | Buy | $0.0003833 | Buy |
| MA 10 | $0.0003485 | Buy | $0.000369 | Buy |
| MA 20 | $0.0003705 | Buy | $0.0003817 | Buy |
| MA 50 | $0.0004533 | Sell | $0.0004417 | Sell |
| MA 100 | $0.0005199 | Sell | $0.000581 | Sell |
| MA 200 | $0.0007993 | Sell | $0.001127 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 53.99 | Neutral |
| Stoch RSI (14) | 98.60 | Sell |
| CCI (20) | 60.04 | Neutral |
| Williams %R (14) | -1.75 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | 21.91 | Buy |
| Bollinger %B (20,2) | 0.71 | Neutral |
| Stochastic %K (14) | 98.25 | Sell |
| TRIX (15) | -1.31 | Sell |
| Awesome (5,34) | -0.00 | Sell |
| Ultimate (7,14,28) | 73.78 | Sell |
| Momentum (10) | 0.00 | Buy |
| Aroon Osc (25) | -36.00 | Sell |
| Hull MA (9) | 0.00 | Buy |
| ADX (14) | 29.29 | Buy |
| ATR (14) | 0.00 | Info |
In the near term, the sentiment remains NEUTRAL with an RSI of 50. The 50-day simple moving average is $0.0004533 and the 200-day simple moving average is $0.0007993, signaling a cautious stance relative to longer-term trends. Support is at $0.0003117 and resistance at $0.0005364, framing a 30-day range from $0.0002965 to $0.0005767.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.0003117 | $0.0004135 | $0.0004166 | 0% | Neutral | |
| $0.0002335 | $0.0003247 | $0.0004888 | -21% | Bearish | |
| $0.0003807 | $0.000562 | $0.0008994 | +36% | Bullish | |
| $0.0002782 | $0.0004323 | $0.0007253 | +5% | Neutral | |
| $0.0001586 | $0.0002583 | $0.0004508 | -38% | Bearish | |
| $0.0003381 | $0.0005756 | $0.001039 | +39% | Bullish | |
| $0.0003535 | $0.0006276 | $0.001168 | +52% | Bullish | |
| $0.0001788 | $0.0003306 | $0.0006321 | -20% | Bearish | |
| $0.0002156 | $0.0004147 | $0.0008129 | 0% | Neutral | |
| $0.0003835 | $0.0007669 | $0.001538 | +85% | Bullish | |
| $0.0003104 | $0.0006899 | $0.001519 | +67% | Bullish | |
| $0.0005873 | $0.001305 | $0.003002 | +216% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.0003117 | $0.0004135 | $0.0004904 | +0.00% |
| June 2026 | $0.0003641 | $0.0004373 | $0.0005447 | +5.76% |
| July 2026 | $0.0003635 | $0.0004439 | $0.0005667 | +1.49% |
| August 2026 | $0.0002976 | $0.0003682 | $0.0004791 | -17.04% |
| September 2026 | $0.0002692 | $0.0003368 | $0.000445 | -8.54% |
| October 2026 | $0.0002968 | $0.0003751 | $0.0005026 | +11.39% |
| November 2026 | $0.0002813 | $0.0003588 | $0.0004865 | -4.36% |
| December 2026 | $0.0002361 | $0.0003037 | $0.0004166 | -15.35% |
Click any year to see its month-by-month GENOME forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, GENOME could reach as high as $0.0004166, with a base case around $0.0004135 and support toward $0.0003117 — roughly 0% from $0.0004135. Price action looks broadly range-bound.
Expect GENOME to range from $0.0002335 to $0.0004888 through 2027. The $0.0003247 average target implies a -21% move from current prices. That is -21% versus the projected 2026 average. Expect choppier, lower action through this leg of the cycle.
The GENOME price prediction for 2028 points to an average of $0.000562 (low $0.0003807, high $0.0008994) — a potential gain of +36% on today's $0.0004135. Momentum favours further upside here.
In 2029, GENOME is projected to trade between $0.0002782 and $0.0007253, averaging $0.0004323 — a potential gain of +5% from today's $0.0004135. That is -23% versus the projected 2028 average. A consolidation phase looks the most probable path here.
GenomesDAO GENOME's 2030 outlook centres on $0.0002583, within a $0.0001586 to $0.0004508 range. That is -40% versus the projected 2029 average. That marks a -38% change versus current levels. A cyclical pullback looks likely — prices rarely move in a straight line.
By 2031, GENOME could reach as high as $0.001039, with a base case around $0.0005756 and support toward $0.0003381 — roughly +39% from $0.0004135. Buyers look set to stay in control over this stretch.
Expect GENOME to range from $0.0003535 to $0.001168 through 2032. The $0.0006276 average target implies a +52% move from current prices. That is up +9% on the projected 2031 average. Momentum favours further upside here.
The GENOME price prediction for 2033 points to an average of $0.0003306 (low $0.0001788, high $0.0006321) — a potential decline of -20% on today's $0.0004135. Expect choppier, lower action through this leg of the cycle.
In 2034, GENOME is projected to trade between $0.0002156 and $0.0008129, averaging $0.0004147 — a potential gain of 0% from today's $0.0004135. That is up +25% on the projected 2033 average. Price action looks broadly range-bound.
GenomesDAO GENOME's 2035 outlook centres on $0.0007669, within a $0.0003835 to $0.001538 range. That is up +85% on the projected 2034 average. That marks a +85% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, GENOME could reach as high as $0.001519, with a base case around $0.0006899 and support toward $0.0003104 — roughly +67% from $0.0004135. Momentum favours further upside here.
Expect GENOME to range from $0.0005873 to $0.003002 through 2050. The $0.001305 average target implies a +216% move from current prices. That is up +89% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in GENOME today (≈ 2,418,379.685611 GENOME) could be worth
$3,156.16
+$2,156.16 (+216%) by 2050 · US Dollar
Based on the average projected GENOME price of $0 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in GENOMEwould be worth at today's price.
$1,000 invested in GENOME on May 27, 2025 (≈ 156,087.095147 GENOME) would be worth
$64.54
-$935.46 (-93.5%) today · 0.06× · US Dollar
Based on a GENOME entry price of $0.006407 vs. today's $0.000414.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.000327 | $1,263.06 | +26.3% |
| 1 month ago | $0.000524 | $789.5 | -21.1% |
| 3 months ago | $0.000585 | $706.38 | -29.4% |
| 6 months ago | $0.00124 | $333.37 | -66.7% |
| 1 year ago | $0.006407 | $64.54 | -93.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our GENOME forecast.
Our base-case forecast reaches $0.00083 around 2050.
Implied market cap at $0.00083: $830K
The multi-year forecast shows a varied path with yearly averages ranging from a low around $0.0002583 (2030) to a high near $0.001305 (2050), and a max forecast up to $0.003002 by 2050. Notable years include a bearish tilt in 2027 (-21.5% RO I) and 2030 (-37.5%), with bullish surges later in 2031 (39.2%), 2032 (51.8%), 2035 (85.5%), 2040 (66.8%), and a strong upside in 2050 (215.6%). Long-run risk includes the potential for negative years amid elevated volatility (annualized volatility at 100%).
These projections imply potential upside if bullish scenarios materialize, but also highlight meaningful downside risk in certain years.
Tap a question to reveal the answer.
2030: min $0.0001586, avg $0.0002583, max $0.0004508; ROI -37.5%; sentiment BEARISH.
The forecast shows mixed outcomes: some years yield positive ROIs (e.g., 2031 39.2%, 2032 51.8%, 2035 85.5%, 2040 66.8%, 2050 215.6%), while others are negative (e.g., 2027 -21.5%, 2030 -37.5%, 2033 -20.1%). These are probabilistic projections and not guarantees.
Yes. The 2050 forecast lists an avg of $0.001305 and a max of $0.003002, indicating the potential to exceed $0.001 under favorable conditions.
All-time high: $0.0586. All-time low: $0.0002974.
The near-term forecast for 2026 shows an average of $0.0004135 with a min of $0.0003117 and a max of $0.0004166, suggesting movement around the current price in the near term.
GenomesDAO GENOME Community Discussion
0Share your GenomesDAO GENOME price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.